Actavis Inc

Micro Merchant Systems in Syosset offers PrimeRx pharmacy software solutions designed to help community pharmacies and family-owned businesses grow. Their scalable solutions and commitment to great customer service make them a top choice for those in the industry. With a focus on providing software solutions tailored to the needs of community pharmacies, Micro Merchant Systems is dedicated to supporting the success of independent pharmacy owners. Request a demo today to see how their innovative technology can benefit your business. Generated from their website's infomation

ProPhase Labs is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE family of lozenges and sugar free tablets clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA approved facility to manufacture Cold-EEZE lozenges and fulfill other contract manufacturing opportunities, and a Pharma division, which conducts research in order to develop and commercialize a pipeline of patented botanical and naturally derived potential prescription drugs. ProPhase also owns 50% of Phusion Laboratories LLC ("Phusion"). Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. The joint venture will formulate and test products to exploit market opportunities within ProPhase's robust OTC distribution channels.

Fera Pharmaceuticals is a specialty pharmaceutical company based in Locust Valley, NY, dedicated to expanding and preserving quality treatment options for patients, families, and healthcare providers. With a focus on eye health, they offer a diverse portfolio of products, starting with Phospholine Iodide, that have the potential to change lives. Recognizing the importance of niche or orphan conditions, Fera Pharmaceuticals is committed to ensuring that those who suffer from these conditions have access to the medicines they need. Through partnerships, licensing, and product development opportunities, they strive to advance treatment options and improve the health and lives of those who rely on their medications.Generated from the website